Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Solid Tumors × Everolimus × Clear all

Phase

Status

Suspended 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 49 Carcinoma, Renal Cell 44 Neoplasm Metastasis 21 Neoplasms 17 Kidney Neoplasms 16 Neuroendocrine Tumors 14 Lymphoma, Mantle-Cell 12 Carcinoma, Non-Small-Cell Lung 11 Recurrence 10 Prostatic Neoplasms 10 Hodgkin Disease 10 Tuberous Sclerosis 9 Stomach Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma, Large B-Cell, Diffuse 9 Lymphoma 9 Glioblastoma 9 Colorectal Neoplasms 9 Brain Neoplasms 9 Lymphoma, Follicular 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Carcinoma 8 Waldenstrom Macroglobulinemia 7 Triple Negative Breast Neoplasms 7 Sarcoma 7 Multiple Myeloma 7 Lymphoma, B-Cell, Marginal Zone 7 Glioma 7 Central Nervous System Neoplasms 7 Carcinoma, Neuroendocrine 7

Interventions

Carboplatin 6 durvalumab 5 Docetaxel 5 talazoparib 4 linifanib 4 Paclitaxel 4 Nivolumab 4 trifluridine tipiracil drug combination 3 tislelizumab 3 depatuxizumab 3 ST 1481 3 S 1 (combination) 3 Panobinostat 3 Cisplatin 3 tremelimumab 2 olaparib 2 motesanib diphosphate 2 TAS-114 2 Sorafenib 2 Rifampin 2 PM 01183 2 MLN 8237 2 Itraconazole 2 Gemcitabine 2 Erlotinib Hydrochloride 2 Bevacizumab 2 Axitinib 2 6-chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-ylamine 2 zimberelimab 1 veliparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01055795 2012-12-24

BEL

Duke University

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡